Brian P Brennan
Overview
Explore the profile of Brian P Brennan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strom N, Gerring Z, Galimberti M, Yu D, Halvorsen M, Abdellaoui A, et al.
medRxiv
. 2024 May;
PMID: 38712091
Obsessive-compulsive disorder (OCD) affects ~1% of the population and exhibits a high SNP-heritability, yet previous genome-wide association studies (GWAS) have provided limited information on the genetic etiology and underlying biological...
2.
Kim B, Kim G, Abe Y, Alonso P, Ameis S, Anticevic A, et al.
Mol Psychiatry
. 2024 Mar;
29(4):1216.
PMID: 38454086
No abstract available.
3.
Kim B, Kim G, Abe Y, Alonso P, Ameis S, Anticevic A, et al.
Mol Psychiatry
. 2024 Feb;
29(4):1063-1074.
PMID: 38326559
White matter pathways, typically studied with diffusion tensor imaging (DTI), have been implicated in the neurobiology of obsessive-compulsive disorder (OCD). However, due to limited sample sizes and the predominance of...
4.
Bertolin S, Alonso P, Martinez-Zalacain I, Menchon J, Jimenez-Murcia S, Baker J, et al.
J Am Acad Child Adolesc Psychiatry
. 2022 Dec;
62(4):403-414.
PMID: 36526161
Objective: Cognitive-behavioral therapy (CBT) is considered a first-line treatment for obsessive-compulsive disorder (OCD) in pediatric and adult populations. Nevertheless, some patients show partial or null response. The identification of predictors...
5.
Brennan B, Schnabel J, Pope Jr H, Hudson J
Front Psychiatry
. 2022 Oct;
13:951065.
PMID: 36186877
Initial controlled trials of the serotonergic antidepressant fluvoxamine showed promise for treatment of mild to moderate COVID-19 in outpatients, although more recent outpatient data have been less encouraging. Turning to...
6.
Ivanov I, Boedhoe P, Abe Y, Alonso P, Ameis S, Arnold P, et al.
J Affect Disord
. 2022 Aug;
318:204-216.
PMID: 36041582
Background: Widely used psychotropic medications for obsessive-compulsive disorder (OCD) may change the volumes of subcortical brain structures, and differently in children vs. adults. We measured subcortical volumes cross-sectionally in patients...
7.
Brennan B, Hudson J
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2022 Jul;
7(7):635-637.
PMID: 35809988
No abstract available.
8.
Pittenger C, Brennan B, Koran L, Mathews C, Nestadt G, Pato M, et al.
Psychiatry Res
. 2021 May;
300:113853.
PMID: 33975093
Obsessive-compulsive disorder (OCD) affects approximately one person in 40 and causes substantial suffering. Evidence-based treatments can benefit many; however, optimal treatment can be difficult to access. Diagnosis is frequently delayed,...
9.
Bruin W, Taylor L, Thomas R, Shock J, Zhutovsky P, Abe Y, et al.
Transl Psychiatry
. 2020 Oct;
10(1):342.
PMID: 33033241
No diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Here, we aimed to identify magnetic resonance imaging (MRI) biomarkers for OCD, using 46 data sets with 2304 OCD patients and...
10.
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos S, et al.
JAMA Psychiatry
. 2020 Aug;
78(1):47-63.
PMID: 32857118
Importance: Large-scale neuroimaging studies have revealed group differences in cortical thickness across many psychiatric disorders. The underlying neurobiology behind these differences is not well understood. Objective: To determine neurobiologic correlates...